Other reported effects : Fatigue, mood changes, or nonspecific symptoms are occasionally reported, but these occur inconsistently, lack clear doseresponse relationships, and are difficult to separate from background rates and expectation effects
Available in lyophilized powder form, these peptides require reconstitution before use
Although anecdotal reports indicate BPC-157 to be a non-toxic peptide with few adverse interactions, further long-term research is required for the FDA to concur with such a notion
,
Targeting the p53-FOXO4 Axis: In senescent cells, the protein FOXO4 binds to p53 and sequesters it in the nucleus, preventing p53 from triggering cell death
however, the absolute risk differences were similar in trials for epilepsy and psychiatric indications